Evidence map›Paper›PMID 34429415›Full record

ArticleNature communications2021

Ten-eleven translocation 1 mediated-DNA hydroxymethylation is required for myelination and remyelination in the mouse brain.

Ming Zhang, Jian Wang, Kaixiang Zhang, Guozhen Lu, Yuming Liu, Keke Ren, Wenting Wang, Dazhuan Xin, Lingli Xu, Honghui Mao and 8 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. The Role of Methylation Modification in Neural Injury and Repair.International journal of molecular sciences · 2025
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 3 countries.

Ming Zhang *Department of Neurobiology, School of Basic Medicine, Fourth Military Medical University, Xi'an, Shaanxi, China.ORCID 0000-0001-9181-5739
Jian Wang *Department of Neurobiology, School of Basic Medicine, Fourth Military Medical University, Xi'an, Shaanxi, China.
Kaixiang Zhang *Department of Neurobiology, School of Basic Medicine, Fourth Military Medical University, Xi'an, Shaanxi, China.
Guozhen LuDepartment of Neurobiology, School of Basic Medicine, Fourth Military Medical University, Xi'an, Shaanxi, China.
Yuming LiuDepartment of Neurobiology, School of Basic Medicine, Fourth Military Medical University, Xi'an, Shaanxi, China.
Keke RenDepartment of Neurobiology, School of Basic Medicine, Fourth Military Medical University, Xi'an, Shaanxi, China.
Wenting WangDepartment of Neurobiology, School of Basic Medicine, Fourth Military Medical University, Xi'an, Shaanxi, China.ORCID 0000-0002-8344-0102
Dazhuan XinDivision of Experimental Hematology and Cancer Biology, Brain Tumor Center, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Lingli XuCenter for molecular medicine, Pediatric Research Institute, Children's Hospital of Fudan University, Shanghai, China.
Honghui MaoDepartment of Neurobiology, School of Basic Medicine, Fourth Military Medical University, Xi'an, Shaanxi, China.
Junlin XingDepartment of Neurobiology, School of Basic Medicine, Fourth Military Medical University, Xi'an, Shaanxi, China.
Xingchun GaoShaanxi Key Laboratory of Brain Disorders, Xi'an Medical University, Xi'an, Shaanxi, China.
Weilin JinInstitute of Cancer Neuroscience, Medical Frontier Innovation Research Center, The First Hospital of Lanzhou University, Lanzhou, China.
Kalen BerryDivision of Experimental Hematology and Cancer Biology, Brain Tumor Center, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.ORCID 0000-0001-9464-8745
Katsuhiko MikoshibaFaculty of Science, Toho University, Funabashi, Japan.ORCID 0000-0002-3487-6970
Shengxi WuDepartment of Neurobiology, School of Basic Medicine, Fourth Military Medical University, Xi'an, Shaanxi, China. shengxi@fmmu.edu.cn.ORCID 0000-0002-3210-9567
Q Richard LuDivision of Experimental Hematology and Cancer Biology, Brain Tumor Center, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. richard.lu@cchmc.org.ORCID 0000-0001-6846-9014
Xianghui ZhaoDepartment of Neurobiology, School of Basic Medicine, Fourth Military Medical University, Xi'an, Shaanxi, China. xianghuizhao@fmmu.edu.cn.ORCID 0000-0003-1165-0140
Air Force Medical University · CNCincinnati Children's Hospital Medical Center · USChildren's Hospital of Fudan University · CNFirst Hospital of Lanzhou University · CNToho University · JPXi'an Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ten-eleven translocation (TET) proteins, the dioxygenase for DNA hydroxymethylation, are important players in nervous system development and diseases. However, their role in myelination and remyelination after injury remains elusive. Here, we identify a genome-wide and locus-specific DNA hydroxymethylation landscape shift during differentiation of oligodendrocyte-progenitor cells (OPC). Ablation of Tet1 results in stage-dependent defects in oligodendrocyte (OL) development and myelination in the mouse brain. The mice lacking Tet1 in the oligodendrocyte lineage develop behavioral deficiency. We also show that TET1 is required for remyelination in adulthood. Transcriptomic, genomic occupancy, and 5-hydroxymethylcytosine (5hmC) profiling reveal a critical TET1-regulated epigenetic program for oligodendrocyte differentiation that includes genes associated with myelination, cell division, and calcium transport. Tet1-deficient OPCs exhibit reduced calcium activity, increasing calcium activity rescues the differentiation defects in vitro. Deletion of a TET1-5hmC target gene, Itpr2, impairs the onset of OPC differentiation. Together, our results suggest that stage-specific TET1-mediated epigenetic programming and intracellular signaling are important for proper myelination and remyelination in mice.

Indexed as

5-MethylcytosineAnimalsBrainCell CycleCell DifferentiationDNADNA-Binding ProteinsDNA MethylationGenomeMiceMice, KnockoutMice, Neurologic MutantsOligodendrogliaOrganogenesisProto-Oncogene ProteinsRemyelination5-hydroxymethylcytosine5-MethylcytosineDNADNA-Binding ProteinsProto-Oncogene ProteinsTET1 protein, mouse

Identifiers

PMID34429415
PMCPMC8385008
OpenAlexW3194320644

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.